Case series are collections of patient case reports with a single exposure or outcome that are evaluated to describe clinical outcomes. They can be useful after drug approval to quantify adverse drug reactions and ensure rare reactions are not missed. However, case series lack a control group, so it is difficult to determine which features are uniquely associated with an exposure or outcome. Overall, case series provide clinical descriptions but not strong evidence of causation.
Case series are collections of patient case reports with a single exposure or outcome that are evaluated to describe clinical outcomes. They can be useful after drug approval to quantify adverse drug reactions and ensure rare reactions are not missed. However, case series lack a control group, so it is difficult to determine which features are uniquely associated with an exposure or outcome. Overall, case series provide clinical descriptions but not strong evidence of causation.
Case series are collections of patient case reports with a single exposure or outcome that are evaluated to describe clinical outcomes. They can be useful after drug approval to quantify adverse drug reactions and ensure rare reactions are not missed. However, case series lack a control group, so it is difficult to determine which features are uniquely associated with an exposure or outcome. Overall, case series provide clinical descriptions but not strong evidence of causation.
Case series are collections of patient case reports with a single exposure or outcome that are evaluated to describe clinical outcomes. They can be useful after drug approval to quantify adverse drug reactions and ensure rare reactions are not missed. However, case series lack a control group, so it is difficult to determine which features are uniquely associated with an exposure or outcome. Overall, case series provide clinical descriptions but not strong evidence of causation.
Download as PPTX, PDF, TXT or read online from Scribd
Download as pptx, pdf, or txt
You are on page 1of 10
Case series
• It is a group or cluster of case reports that may be
generated by a single clinician, group of clinicians, a hospital, pharmaceutical company, or most importantly a regulatory agency.
• Case series are collections of patients, all of whom have
a single exposure, whose clinical outcomes are then evaluated and described.
• Case series can be collections of patients with a single
outcome, looking at their antecedent exposures • E g : case series on thalidomide induced phocomelia and fatal alcohol syndrome
• Occasionally, case series may produce a false alarm
when the relationship is strictly spurious. • For e.g. antiemetic doxylamine /pyridoxine, where original case series suggested it was a teratogen, but this was not confirmed by analysis of all available data. Advantages • After drug marketing, case series are most useful for two related purposes.
Firstly they can be useful for quantifying the incidence
of an ADR . The so-called “Phase IV” post marketing surveillance study of prazosin was conducted, to quantitate the incidence of first-dose syncope from prazosin. • Secondly, they can be useful for being certain that any particular adverse effect of concern does not occur when observed in a population which is larger than that studied prior to drug marketing.
The “Phase IV” postmarketing surveillance study was
conducted for cimetidine. Metiamide was an H-2 blocker, which was withdrawn after marketing outside the US because it caused agranulocytosis . Since cimetidine is chemically related to metiamide there was a concern that cimetidine might also cause Limitation • In the absence of a control group, one cannot be certain which features in the description of the patients are unique to the exposure, or outcome.
• As an example, one might have a case series from a particular
hospital of 100 individuals with a certain disease, and note that all were men over the age of 60. This might lead one to conclude that this disease seems to be associated with being a man over the age of 60. Conclusion • Case series is a pharmacoepidemiology study design.
• It analyse the data from various case reports in series.
• Case series are use full after marketing of drug to quantifying
the incidence of an adverse reaction and to develop certainty between adverse reaction and exposure of the drug.
• Case series are not very useful in determining causation, but
provide clinical descriptions of a disease or of patients who receive an exposure. PARTS 1. TITLE 2. KEYWORDS 3. ABSTRACT 4. INTRODUCTION 5. INDIVIDUAL CASE PRESENTATION 6. DISCUSSION 7. CONCLUSION 8. REFERENCE